Learn More
Cayman Chemical nprIlysInCD10N-Term Rabb 100uL

Supplier: Cayman Chemical 32276100 UL
An adenosine A2A and A2B receptor dual antagonist inhibits the ability of adenosine to suppress activation of human CD4 or CD8 T cells as well as monocyte-derived dendritic cells in vitro reduces tumor growth in an AT3-OVA syngeneic mouse model alone or in combination with doxorubicin acts synergistically with an anti-PD-1 antibody to reduce tumor growth in a B16/F10 syngeneic mouse model
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.